๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Percutaneous Coronary Intervention
Clinical trial register · China

Percutaneous Coronary Intervention Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 6 Xi'an 5 Nanjing 2 Hefei 2 Lanzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing6 Xi'an5 Nanjing2 Hefei2 Lanzhou2
All 17 locations
Target enrolment
to

Percutaneous Coronary Intervention trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)
NCT07332494Coronary Heart Disease, Percutaneous Coronary Intervention
Beijing Anzhen Hospital
Not applicable
792
Beijing, Dalian, Jilin City
2026-01
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
IVUS-FFR Accuracy for Coronary Stenosis
NCT07446023Percutaneous Coronary Intervention, Intravenous Ultrasound, Coronary Physiology
China National Center for Cardiovascular Diseases
Not applicable
292
Beijing
2025-07-01
Not yet open
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
Xijing Hospital
Not applicable
12,000
Xi'an
2025-02-20
Active, closed
Efficacy and Safety of Colchicine After PCI
NCT06472908Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
8,862
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Harbin, Zhengzhou, Enshi
2024-07-09
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
NCT05638867Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome
China National Center for Cardiovascular Diseases
Phase 4
3,944
Beijing
2023-11-25
Active, closed
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention, Cardiovascular Events
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,212
Nanjing
2023-03-30
Recruiting
Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention
NCT04937699Acute Coronary Syndrome, Percutaneous Coronary Intervention
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
2,690
Hangzhou
2023-03-28
Recruiting
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140Atrial Fibrillation, Percutaneous Coronary Intervention
Xijing Hospital
Not applicable
1,386
Xi'an
2022-09-01
Recruiting
A Cohort of Patients Undergoing Percutaneous Coronary Intervention
NCT05719545Acute Coronary Syndrome, Percutaneous Coronary Intervention, Myocardial Infarction, Unstable Angina
Su Guohai
Observational
10,000
Jinan
2021-12-01
Recruiting
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
NCT04912518ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection
Harbin Medical University
Not applicable
250
Hefei, Lanzhou, Harbin, Mudanjiang, Zhengzhou, Wuhan, Xi'an, Taiyuan
2021-05-27
Active, closed
Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention
NCT03852082Coronary Heart Disease, Percutaneous Coronary Intervention, Depression
Nanjing First Hospital, Nanjing Medical University
Observational
2,600
Nanjing
2019-08-28
Recruiting
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
NCT03378934Coronary Artery Disease, Percutaneous Coronary Intervention
Peking Union Medical College Hospital
Phase 4
64
Beijing
2018-09-26
Recruiting
PCI in Beijing Friendship Hospital
NCT05728580Cardiovascular Diseases, Percutaneous Coronary Intervention
Beijing Friendship Hospital
Observational
10,000
Beijing
2017-12-31
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/percutaneous-coronary-intervention

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Percutaneous Coronary Intervention.

How many Percutaneous Coronary Intervention trials are recruiting in China?

10 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Percutaneous Coronary Intervention), 15 studies
PhaseStudiesRecruitingShare
Not applicable6340%
Observational5433.3%
Phase 43320%
Phase 3106.7%

Most active sponsors

Lead sponsors with the most studies (Percutaneous Coronary Intervention)
Lead sponsorStudiesRecruiting
Xijing Hospital43
China National Center for Cardiovascular Diseases22
Nanjing First Hospital, Nanjing Medical University20
Beijing Anzhen Hospital10
Beijing Friendship Hospital11
Harbin Medical University11
Peking Union Medical College Hospital11
Second Affiliated Hospital, Zhejiang University, School of Medicine11
Su Guohai11
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.